letrozole tablet
jiangsu hengrui pharmaceuticals co., ltd. - letrozole (unii: 7lkk855w8i) (letrozole - unii:7lkk855w8i) - letrozole 2.5 mg - letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. letrozole tablets are indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. the effectiveness of letrozole tablets in extended adjuvant treatment of early breast cancer is based on an analysis of disease-free survival in patients treated with letrozole tablets for a median of 60 months [ see clinical studies ( 14.2, 14.3) ]. letrozole tablets are indicated for first-line treatment of postmenopausal women with hormone receptor positive or unknown, locally advanced or metastatic breast cancer. letrozole tablets are also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy [
letrozole galenicum health 2.5 mg film-coated tablets
galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - film-coated tablet - letrozole 2.5 mg - endocrine therapy
phl-letrozole tablet
pharmel inc - letrozole - tablet - 2.5mg - letrozole 2.5mg - antineoplastic agents
dom-letrozole tablet
dominion pharmacal - letrozole - tablet - 2.5mg - letrozole 2.5mg - antineoplastic agents
mylan-letrozole tablet
mylan pharmaceuticals ulc - letrozole - tablet - 2.5mg - letrozole 2.5mg - antineoplastic agents
co letrozole tablet
cobalt pharmaceuticals company - letrozole - tablet - 2.5mg - letrozole 2.5mg - antineoplastic agents
ipg-letrozole tablet
marcan pharmaceuticals inc - letrozole - tablet - 2.5mg - letrozole 2.5mg - antineoplastic agents
myl-letrozole tablet
mylan pharmaceuticals ulc - letrozole - tablet - 2.5mg - letrozole 2.5mg - antineoplastic agents
taro-letrozole tablet
sun pharma canada inc - letrozole - tablet - 2.5mg - letrozole 2.5mg - antineoplastic agents
zinda-letrozole tablet
stason pharmaceuticals inc - letrozole - tablet - 2.5mg - letrozole 2.5mg - antineoplastic agents